CVS Health exceeded second-quarter earnings and revenue expectations, driven by strong performance in its insurance, pharmacy, and health services segments. The company raised its 2026 profit guidance to $7.90-$8.10 per share and revenue outlook to at least $414 billion, up from previous estimates. Aetna, CVS's insurance unit, showed signs of recovery with improved medical cost management and a lower medical benefit ratio, contributing to the positive outlook. CVS also announced a partnership with Eli Lilly to offer new obesity treatments via its app, expanding patient access starting in Q4. Despite optimism, CVS remains cautious about high medical costs and economic challenges ahead.
